COX dispensers trademark owned by medmix Switzerland Ltd.

    April 19, 2024

    COX Handheld Dispensers for One and Two-Component Materials: PC COX legacy since 1958 inherited by medmix Switzerland Ltd.

    medmix Switzerland AG, a leading manufacturer of industrial dispensers, is the exclusive producer of authentic handheld dispensers for one and two-component materials made in England under the COX trademark. The company is the sole owner of this trademark for its authentic COX dispensers made in England based on the tradition, quality and legacy of P.C. Cox and protects it against illegal copiers worldwide.

    Background:

    • PC Cox Group Ltd., headquartered in Hungerford, United Kingdom, was founded in 1958 and established the P.C. COX legacy of quality and performance from the beginning. In 2016, it was acquired by the Sulzer Group and subsequently renamed as Sulzer Mixpac UK and integrated into the Sulzer Applicator Systems (APS) division.
    • Following the spin-off of the APS division as the medmix group and the renaming of Sulzer Mixpac UK as medmix UK, the dispenser business remains an integral part of the group’s portfolio.
    • PC Cox was renowned for its high-quality dispensers used in sealing and adhesive applications across various industries. The legacy of the P.C. Cox design, development and production continues to thrive in England. At medmix UK, our personnel and teams meticulously handcraft all COX dispensers in a modern, expanded facility located in Hungerford, England.

    Strength in Innovation:

    • medmix Switzerland AG, in collaboration with other dispenser brands, offers an extensive product lineup. COX dispensers, known for their reliability and precision, enhance medmix Switzerland’s reputation as a technological leader in industrial one and two-component applications worldwide. Many of the younger original P.C. Cox technology and manufacturing employees remain with us today.
    • The company’s commitment to excellence extends beyond manufacturing. medmix Switzerland is a trusted provider of mixing, dosing and delivery systems on the global stage.

    Learn More:

    For detailed information about our products and services, please visit medmix.swiss and coxdispenser.com. Additional insights into this acquisition can be found in the press release issued by Sulzer Ltd. on April 5, 2016.

    Combatting Counterfeits:

    Many COX counterfeits in China falsely state that they are made by us at our predecessor legal entity, P.C. Cox in Newbury, England, which has not existed under that name or in that location for several years. Such COX counterfeits do not benefit from the technology, tradition, heritage, quality and performance of the authentic made-in-England COX dispensers, nor do they benefit from the medmix guarantee of performance and quality. medmix Switzerland Ltd. takes decisive action against illegal copiers of our COX dispensers, particularly in China. Our successful efforts in protecting our trademarks have been instrumental in maintaining the integrity of our brand. We remain steadfast in our commitment to safeguarding our intellectual property.

    Note: This press release is subject to updates and revisions as needed.

     

    About medmix

    medmix is a global leader in high-precision delivery devices, with leading positions in healthcare, consumer and industrial end-markets. Our customers benefit from our dedication to innovation and technological advancement that has resulted in over 900 active patents. Our 14 production sites worldwide together with our highly motivated and experienced team of nearly 2’700 employees are at service of our customers with uncompromising quality, proximity and agility. medmix is headquartered in Baar, Switzerland. Our shares are traded on the SIX Swiss Exchange (SIX: MEDX). www.medmix.swiss

     

    Inquiries:

    Investor Relations: investorrelations@medmix.com

    Media Relations: communications@medmix.com

     

    This document may contain forward-looking statements including, but not limited to, projections of financial developments, market activity, or future performance of products and solutions containing risks and uncertainties. These forward-looking statements are subject to change based on known or unknown risks and various other factors that could cause actual results or performance to differ materially from the statements made herein.

     

    CONTACT

    James Amoroso

    Head of Investor Relations

    +41 41 723 73 57

    investorrelations@medmix.com

    Malaika Schroeder

    Global Corporate Communications Lead

    communications@medmix.com